Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

803 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Magnetic resonance imaging for accelerated assessment of drug effect and prediction of subsequent radiographic progression in rheumatoid arthritis: a study of patients receiving combined anakinra and methotrexate treatment.
Østergaard M, Duer A, Nielsen H, Johansen JS, Narvestad E, Ejbjerg BJ, Baslund B, Møller JM, Thomsen HS, Petersen J. Østergaard M, et al. Ann Rheum Dis. 2005 Oct;64(10):1503-6. doi: 10.1136/ard.2005.038018. Epub 2005 Mar 18. Ann Rheum Dis. 2005. PMID: 15778238 Free PMC article. Clinical Trial.
Are bone erosions detected by magnetic resonance imaging and ultrasonography true erosions? A comparison with computed tomography in rheumatoid arthritis metacarpophalangeal joints.
Døhn UM, Ejbjerg BJ, Court-Payen M, Hasselquist M, Narvestad E, Szkudlarek M, Møller JM, Thomsen HS, Østergaard M. Døhn UM, et al. Among authors: ostergaard m. Arthritis Res Ther. 2006;8(4):R110. doi: 10.1186/ar1995. Arthritis Res Ther. 2006. PMID: 16848914 Free PMC article.
No erosive progression revealed by MRI in rheumatoid arthritis patients treated with etanercept, even in patients with persistent MRI and clinical signs of joint inflammation.
Døhn UM, Skjødt H, Hetland ML, Vestergaard A, Møller JM, Knudsen LS, Ejbjerg BJ, Thomsen HS, Ostergaard M. Døhn UM, et al. Among authors: ostergaard m. Clin Rheumatol. 2007 Nov;26(11):1857-61. doi: 10.1007/s10067-007-0589-y. Epub 2007 Feb 27. Clin Rheumatol. 2007. PMID: 17332974
Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure.
Møller Døhn U, Boonen A, Hetland ML, Hansen MS, Knudsen LS, Hansen A, Madsen OR, Hasselquist M, Møller JM, Østergaard M. Møller Døhn U, et al. Among authors: ostergaard m. Ann Rheum Dis. 2009 Oct;68(10):1585-90. doi: 10.1136/ard.2008.097048. Epub 2008 Nov 19. Ann Rheum Dis. 2009. PMID: 19019887 Clinical Trial.
[Continuous quick development of rheumatology].
Madsen OR, Terslev L, Tarp U, Jacobsen S, Ostergaard M. Madsen OR, et al. Among authors: ostergaard m. Ugeskr Laeger. 2009 Mar 23;171(13):1092. Ugeskr Laeger. 2009. PMID: 19321087 Danish. No abstract available.
No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study.
Døhn UM, Ejbjerg B, Boonen A, Hetland ML, Hansen MS, Knudsen LS, Hansen A, Madsen OR, Hasselquist M, Møller JM, Ostergaard M. Døhn UM, et al. Among authors: ostergaard m. Ann Rheum Dis. 2011 Feb;70(2):252-8. doi: 10.1136/ard.2009.123729. Epub 2010 Oct 26. Ann Rheum Dis. 2011. PMID: 20980282 Clinical Trial.
803 results